{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-25-000033","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2025-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.137825+00:00","generated_at":"2026-05-17T07:10:31.533369+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kewaunee Scientific Q1 sales up 47%; EPS $1.04; backlog $205M; expects FY EBITDA increase","bullets":["Sales $71.1M (+46.9% YoY); diluted EPS $1.04 vs $0.74; net earnings $3.09M.","Domestic sales $54.4M (+53%) driven by Nu Aire acquisition and improved productivity.","Backlog $205M near historical highs; CEO warns of uneven quarterly performance ahead.","Expects better unadjusted EBITDA in FY2026 vs FY2025 despite strategic investments.","Corporate segment pre-tax loss $3.1M due to SOX 404(b) compliance and growth investments."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-25-000033","json":"https://secwatch.observer/filing/0000055529-25-000033.json","markdown":"https://secwatch.observer/filing/0000055529-25-000033.md","text":"https://secwatch.observer/filing/0000055529-25-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552925000033/0000055529-25-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552925000033/kequ-20250910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:10:31.533369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}